Binance listing sparks interest: Market participants on social media are actively discussing the recent addition of CBRS to Binance's tokenized stock offerings alongside several other equities. The move provides 24/5 trading access with zero commissions, drawing attention to the stock's liquidity potential. Observers note this development could fragment spot trading volumes across platforms.
Price action draws scrutiny: Recent posts highlight CBRS trading around $205 after an 8.83% decline amid broader AI-chip sector pressures. Analysts point to elevated valuations near 74 times sales as a key factor in the pullback from post-IPO levels. Some traders reference the $160 support zone as critical if selling intensifies.
Community groups emerge: Dedicated investor channels for CBRS holders are being promoted to facilitate discussions on updates and strategy. Sentiment remains mixed as participants weigh listing benefits against ongoing litigation risks from the May IPO. Overall discussion reflects cautious monitoring of volatility.
Note: This discussion summary was generated from an AI condensation of post data.
Cerebras Insider Trading Activity
Cerebras insiders have traded $CBRS stock on the open market 130 times in the past 6 months. Of those trades, 0 have been purchases and 130 have been sales.
Here’s a breakdown of recent trading of $CBRS stock by insiders over the last 6 months:
- DHIRAJ MALLICK (Chief Operating Officer) has made 0 purchases and 58 sales selling 79,445 shares for an estimated $14,117,476.
- ANDREW D. FELDMAN (CEO, President) has made 0 purchases and 12 sales selling 17,990 shares for an estimated $3,113,282.
- YAGNESH PATEL (Chief Accounting Officer) has made 0 purchases and 44 sales selling 10,079 shares for an estimated $1,739,513.
- SEAN LIE (Chief Technology Officer) has made 0 purchases and 16 sales selling 10,033 shares for an estimated $1,706,311.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Cerebras Hedge Fund Activity
We have seen 1 institutional investors add shares of Cerebras stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSMUTUAL PRIVATE WEALTH & TRUST, FSB added 200 shares (+inf%) to their portfolio in Q2 2026, for an estimated $44,200
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Cerebras Analyst Ratings
Wall Street analysts have issued reports on $CBRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 06/08/2026
To track analyst ratings and price targets for Cerebras, check out Quiver Quantitative's $CBRS forecast page.
Cerebras Price Targets
Multiple analysts have issued price targets for $CBRS recently. We have seen 11 analysts offer price targets for $CBRS in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Paul Meeks from Freedom Capital Markets set a target price of $209.0 on 06/30/2026
- N. Quinn Bolton from Needham set a target price of $300.0 on 06/24/2026
- Matt Bryson from Wedbush set a target price of $280.0 on 06/24/2026
- Joseph Moore from Morgan Stanley set a target price of $273.0 on 06/24/2026
- Kevin Cassidy from Rosenblatt set a target price of $300.0 on 06/24/2026
- Timothy Arcuri from UBS set a target price of $320.0 on 06/24/2026
- Richard Shannon from Craig-Hallum set a target price of $325.0 on 06/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
